Shuo Luo is a highly motivated Senior Scientist at Merck, dedicated to improving human health by exploring the molecular mechanisms underlying neurodegenerative and autoimmune disorders. Previously, they served as an Associate Specialist at the University of California, San Francisco, where they identified the molecular functions of the multiple sclerosis risk gene TMEM39A. With a Ph.D. in Neuroscience from Washington University in St. Louis, Shuo has led multiple neuroscience projects and independently contributed to research that has resulted in over ten publications in esteemed journals. Their work includes generating engineered cell lines using CRISPR technology at Synthego and EditCo Bio.
This person is not in the org chart
This person is not in any teams
This person is not in any offices